Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia

Схожие документы

• Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia
  по: Fiona Fernando, и др.
  Опубликовано: (2025-10-01)
• Molecular Response of Chronic Myeloid Leukaemia Patients to Tyrosine Kinase Inhibitors
  по: Md. Imran Hossain, и др.
  Опубликовано: (2020-05-01)
• Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients
  по: Sarah Allegra, и др.
  Опубликовано: (2023-09-01)
• Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors
  по: Yuriko Nishiyama-Fujita, и др.
  Опубликовано: (2022-12-01)
• Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations
  по: Simone Claudiani, и др.
  Опубликовано: (2020-05-01)